Results 191 to 200 of about 556,852 (338)
Iatrogenic Alterations of Immunologic Surveillance in Man and Their Influence on Malignancy [PDF]
Agosin M. +85 more
core +1 more source
Evaluation of the use of radiotherapy to palliatively treat appendicular histiocytic sarcomas in flatcoat retrievers [PDF]
Charles Pittaway, Jane Dobson
openalex +1 more source
Background Information on mitoxantrone pharmacokinetics in children is lacking and reduced dosing regimens applied to infants are supported by limited scientific rationale. The current study characterized mitoxantrone pharmacokinetics in a childhood acute myeloid leukaemia patient population and provides a data‐informed assessment of dosing.
Andrew M. Brandon +13 more
wiley +1 more source
Adult Primary Hepatic Sarcoma Presenting as a Chronic Expanding Hematoma. [PDF]
Fujii TY, Kimura T, Nakatsuka S.
europepmc +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
Distraction Osteogenesis Reconstruction Following Resection of Bone Sarcomas [PDF]
Anthony Bozzo +4 more
openalex +1 more source
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source

